Jiseung Kang

Jiseung Kang

Auto-generated profile, based on publicly available information

Jiseung Kang

School of Health and Environmental Science, Korea University College of Health Science, Seoul, Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YCYujin Choi
Yujin Choi
HKHyeon Jin Kim
Hyeon Jin Kim
JPJaeyu Park
Jaeyu Park
MLMyeongcheol Lee
Myeongcheol Lee
SKSunyoung Kim
Sunyoung Kim
DYDong Keon Yon
Dong Keon Yon
Considering the significant burden of post-acute COVID-19 conditions among patients infected with SARS-CoV-2, we aimed to identify the risk of acute respiratory complications or post-acute respiratory sequelae. A binational population-based cohort study was conducted to analyze the risk of acute respiratory complications or post-acute respiratory sequelae after SARS-CoV-2 infection. We used a Korean nationwide claim-based cohort (K-COV-N; n = 2,312,748; main cohort) and a Japanese claim-based cohort (JMDC; n = 3,115,606; replication cohort) after multi-to-one propensity score matching. Among 2,312,748 Korean participants (mean age, 47.2 years [SD, 15.6]; 1,109,708 [48.0%] female), 17.1% (394,598/2,312,748) were infected with SARS-CoV-2. The risk of acute respiratory complications or post-acute respiratory sequelae is significantly increased in people with SARS-CoV-2 infection compared to the general population (acute respiratory complications: HR, 8.06 [95% CI, 6.92-9.38]; post-acute respiratory sequelae: 1.68 [1.62-1.75]), and the risk increased with increasing COVID-19 severity. We identified COVID-19 vaccination as an attenuating factor, showing a protective association against acute or post-acute respiratory conditions. Furthermore, while the excess post-acute risk diminished with time following SARS-CoV-2 infection, it persisted beyond 6 months post-infection. The replication cohort showed a similar pattern in the association. Our study comprehensively evaluates respiratory complications in post-COVID-19 conditions, considering attenuating factors such as vaccination status, post-infection duration, COVID-19 severity, and specific respiratory conditions.

6 June 2025 in Journal of Medical Virology
Verified
Journal Article
Open access
MRMasoud Rahmati
Masoud Rahmati
RURAPHAEL UDEH
RAPHAEL UDEH
JKJiseung Kang
Jiseung Kang
XDXenia Dolja‐Gore
Xenia Dolja‐Gore
Mark McEvoyMark McEvoy
Mark McEvoy
LBLaurent Boyer
Laurent Boyer
The symptoms of long COVID are well‐documented. However, the long‐term effects beyond 2 years remain poorly understood due to a lack of data. This systematic review and meta‐analysis examined the prevalence of persistent symptoms in COVID‐19 survivors 3 years following initial SARS‐CoV‐2 infection. PubMed, MEDLINE (Ovid), CENTRAL, Web of Science, Scopus, and Embase were searched from inception of the databases up to July 20, 2024, by two independent researchers for articles reporting on the prevalence of persistent symptoms 3 years' post‐infection of people who survived COVID‐19 infection. We employed a random‐effect model for the pooled analysis, and the meta‐analytical effect size was prevalence for the applicable end‐points, I2 statistics, and quality assessment of included studies using the Newcastle‐Ottawa Scale. Eleven articles were included after the literature search yielded 223 potentially relevant articles. We found that among patients with long COVID, fatigue, sleep disturbances, and dyspnea were the most common symptoms. Pooled analysis showed that the proportion of individuals experiencing at least one persistent symptom 3 years post‐COVID‐19 is 20% (95% confidence interval [CI]: 8–43). The prevalence of persistent symptoms was dyspnea (12%; 95% CI: 10–15), fatigue (11%; 95% CI: 6–20), insomnia (11%; 95% CI: 2–37), loss of smell (7%; 95% CI: 5–8), loss of taste (7%; 95% CI: 3–16), and anxiety (6%; 95% CI: 1–32). Prevalence of other findings include impaired diffusion capacity (42%; 95% CI: 34–50) and impaired forced expiratory volume in 1 s (10%; 95% CI: 8–12). Our findings confirm the persistence of unresolved symptoms 3 years post‐COVID‐19 infection, with implications for future research, healthcare policy, and patient care.

16 December 2024 in eClinicalMedicine
Verified
Journal Article
Open access
SKSoeun Kim
Soeun Kim
HLHayeon Lee
Hayeon Lee
SWSelin Woo
Selin Woo
HLHyeri Lee
Hyeri Lee
JPJaeyu Park
Jaeyu Park
DYDong Keon Yon
Dong Keon Yon
Drug use disorder (DUD) poses a major public health crisis globally, necessitating immediate attention to global trends and future projections to develop effective health policies and interventions. Thus, we aimed to estimate the global trends in DUD mortality rates from 1990 to 2021 and future projections of DUD deaths until 2040 across 73 countries. In this time-series analysis and modelling study, we investigated the global trends in DUD mortality rates from 1990 to 2021 using the WHO Mortality Database and forecasted future trends through 2040. Global trend analysis was analysed using a locally weighted scatter plot smoother (LOESS) curve, and future projections were calculated based on a Bayesian age-period-cohort analysis. In addition, we performed a decomposition analysis to identify the variations in DUD deaths, specifically examining factors such as population growth, ageing, and epidemiological changes. Of the 73 countries included in the analysis of DUD mortality, 45 were high-income countries (HICs), and 28 were low to middle-income countries (LMICs). The LOESS estimates of the global DUD mortality rate were 1.84 deaths per 1,000,000 people (95% CI, −0.44 to 4.12) in 1990 and 13.09 deaths per 1,000,000 people (95% CI, 10.74–15.43) in 2021. Notably, HICs showed a significant increase in DUD mortality from 1.43 deaths per 1,000,000 people (95% CI, −1.55 to 4.42) in 1990 to 17.19 deaths per 1,000,000 people (95% CI, 13.84–20.53) in 2021. A significant increase in DUD mortality was observed among individuals aged 25–64 and males. Our analysis also identified associations between DUD mortality rates and several log-transformed parameters, including Human Development Index (β, 14.92; p < 0.0001), Socio-demographic Index (β, 11.80; p < 0.0001), reverse Gender Gap Index (β, −12.02; p < 0.0001), and Gini coefficient (β, −1.84; p < 0.0001). From 1990 to 2021, the increase in the number of DUD deaths globally can be attributed to two prominent factors: epidemiological change and population growth. In HICs, the impacts of epidemiological changes for increasing DUD mortality rates were particularly prominent compared to other factors. In the Bayesian age-period-cohort models, the predicted number of global DUD deaths up to 2040 were estimated to increase from 25.95 deaths per 1,000,000 people (95% credible interval [CrI], 24.72–27.28) in 2021 to 38.45 (95% CrI, 30.48–49.33) in 2030, and 42.43 (95% CrI, 23.67–77.77) in 2040. An increasing trend in global DUD mortality was observed from 1990 to 2021, especially in HICs. Future DUD deaths were also predicted to increase until 2040 at the global level. Therefore, these findings suggest urgent and proactive strategies for DUD to reduce the mortality rates related to DUD are needed. However, further prospective research that accounts for potential confounding factors, such as socioeconomic variables and the quality of reporting data from individual countries, is imperative for more accurate estimation. 10.13039/501100003725 National Research Foundation and 10.13039/501100014188 Ministry of Science and ICT of South Korea .

30 May 2024 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
JKJiseung Kang
Jiseung Kang
HLHyeri Lee
Hyeri Lee
SYSeungyeong Yu
Seungyeong Yu
MLMyeongcheol Lee
Myeongcheol Lee
HKHyeon Jin Kim
Hyeon Jin Kim
DYDong Keon Yon
Dong Keon Yon

5 May 2025 in European Heart Journal
Verified
Journal Article
Closed access
SLSooji Lee
Sooji Lee
KLKyeongmin Lee
Kyeongmin Lee
JOJiyeon Oh
Jiyeon Oh
HKHyeon Jin Kim
Hyeon Jin Kim
YSYejun Son
Yejun Son
DYDong Keon Yon
Dong Keon Yon
Background and Aims: Despite the potential association between herpes zoster infection and cardiovascular events, limited studies have investigated the relationship between live zoster vaccination and cardiovascular outcomes. This large-scale, population-based cohort study with a long-term follow-up aimed to investigate the association between live zoster vaccination and the risk of various cardiovascular events. Methods: Data on comprehensive information of individuals aged ≥50 years from South Korea (n = 2 207 784) were included from 1 January 2012, to 31 December 2021. National insurance information from the Korea Health Insurance Review and Assessment Service, the national health examination results from the Korean National Health Insurance Service, and the live zoster vaccination data from the Korea Disease Control and Prevention Agency were merged. The risk of incident cardiovascular outcomes after live zoster vaccination was assessed compared with unvaccinated individuals. The primary outcome was the risk of cardiovascular diseases based on International Classification of Diseases, Tenth Revision code diagnosis. In propensity score–based overlap weighted cohorts, Cox proportional hazard models were used to estimate hazard ratios (HRs) for overall and specific cardiovascular outcomes, while calculating restricted mean survival time (RMST) for each outcome. The observation period was from 1 January 2012, to 31 January 2024. Multiple stratification analyses were performed. Results: After applying propensity score–based overlap weighting, 1 271 922 individuals were included [mean age, 61.3 years (standard deviation, 3.4); 548 986 (43.2%) male; median follow-up time, 6.0 years] in overlap-weighted cohort. Live zoster vaccination was associated with lower risks of overall cardiovascular events [HR 0.77, 95% confidence interval (CI) 0.76–0.78], particularly major adverse cardiovascular events [0.74 (0.71–0.77)], heart failure [0.74 (0.70–0.77)], cerebrovascular disorders [0.76 (0.74–0.78)], ischaemic heart disease [0.78 (0.76–0.80)], thrombotic disorders [0.78 (0.74–0.83)], and dysrhythmia [0.79 (0.77–0.81)]. The RMST difference for overall cardiovascular events following live zoster vaccination was 95.14 days per decade (95% CI 94.99–95.30). The protective association persisted up to 8 years, with the greatest reduction observed 2–3 years post-vaccination. The decrease in cardiovascular disease risk was more pronounced among males, individuals aged <60 years, those with unhealthy lifestyle habits, and those from low-income households and rural residents. Conclusions: These findings suggest that live zoster vaccination may be beneficial as a public health strategy with potential implications for cardiovascular disease burden in the general population. This strategy may help address health disparities and mortality linked to cardiovascular complications.

17 May 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
HKHyejun Kim
Hyejun Kim
YSYejun Son
Yejun Son
HLHojae Lee
Hojae Lee
JKJiseung Kang
Jiseung Kang
AHAhmed Hammoodi
Ahmed Hammoodi
DYDong Keon Yon
Dong Keon Yon
Background: Suicide is the second-leading cause of death among adolescents and is associated with clusters of suicides. Despite numerous studies on this preventable cause of death, the focus has primarily been on single nations and traditional statistical methods. Objective: This study aims to develop a predictive model for adolescent suicidal thinking using multinational data sets and machine learning (ML). Methods: We used data from the Korea Youth Risk Behavior Web-based Survey with 566,875 adolescents aged between 13 and 18 years and conducted external validation using the Youth Risk Behavior Survey with 103,874 adolescents and Norway’s University National General Survey with 19,574 adolescents. Several tree-based ML models were developed, and feature importance and Shapley additive explanations values were analyzed to identify risk factors for adolescent suicidal thinking. Results: When trained on the Korea Youth Risk Behavior Web-based Survey data from South Korea with a 95% CI, the XGBoost model reported an area under the receiver operating characteristic (AUROC) curve of 90.06% (95% CI 89.97-90.16), displaying superior performance compared to other models. For external validation using the Youth Risk Behavior Survey data from the United States and the University National General Survey from Norway, the XGBoost model achieved AUROCs of 83.09% and 81.27%, respectively. Across all data sets, XGBoost consistently outperformed the other models with the highest AUROC score, and was selected as the optimal model. In terms of predictors of suicidal thinking, feelings of sadness and despair were the most influential, accounting for 57.4% of the impact, followed by stress status at 19.8%. This was followed by age (5.7%), household income (4%), academic achievement (3.4%), sex (2.1%), and others, which contributed less than 2% each. Conclusions: This study used ML by integrating diverse data sets from 3 countries to address adolescent suicide. The findings highlight the important role of emotional health indicators in predicting suicidal thinking among adolescents. Specifically, sadness and despair were identified as the most significant predictors, followed by stressful conditions and age. These findings emphasize the critical need for early diagnosis and prevention of mental health issues during adolescence.